Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 17 Source: Company
- €541.4 million turnover
-
-€146.6 million
profit - 2,000 employees
-
31st Dec 16 Source: CRO
- €438 million turnover
-
€147.3 million
profit - 380 employees
- 5 more years available »
Ranking
By Turnover
(€541.4 million)- 146th in Top Companies
- 20th in Health
- 17th in Pharma
By Employees
(2,000)- 122nd in Top Companies
- 19th in Health
- 10th in Pharma
-
- 2,000
- €541.4 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- 1:55pm Medtronic shares ventilator design publicly to increase production
- 1:47pm Irish economy will suffer mildest shock to output from coronavirus - OECD
- 1:35pm Covid-19 pandemic has ‘limited impact’ on Fusion Antibodies
- 12:02pm Shopping centre owner sees rental income drop by two-thirds
- 11:51am Euro area sentiment plunges as coronavirus shutdown continues